Study Evaluating the Safety, Tolerability and Efficacy of PBT2 in Patients With Early Alzheimer's Disease
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to determine the safety, tolerability and efficacy of 2 doses of
PBT2 administered for 12 weeks compared to placebo in patients with early Alzheimer's disease
treated with an acetylcholinesterase inhibitor.